数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

   FBIO
-- -- --

今开：-- 昨收：-- 最高：-- 最低：--
成交量：--万手 市盈率：-- 总市值($)：-- 换手率：--
加入自选股

首页概览 公司概况 财务分析 高管介绍 股本结构 公司新闻

股本结构

单位：万股
公告日期 2024-03-28 2024-01-03 2024-03-28 2024-01-03 2023-11-13 2023-11-09
证券总股本 1923.45 1837.68 1509.31 1507.34 1482.78 894.28
普通股本 1923.45 1837.68 1509.31 1507.34 1482.78 894.28
优先股 342.71 未披露 342.71 未披露 342.71 342.71
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-03-27 2024-01-02 2023-12-31 2023-12-28 2023-11-14 2023-11-03
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-03-28 1923.45 342.71 定期报告 2024-03-27
2024-01-03 1837.68 未披露 定期报告 2024-01-02
2024-03-28 1509.31 342.71
更多>>
From December 31, 2022 to December 31, 2023 Exercise of warrants for cash Common shares issued for dividend on partner company's convertible preferred shares Issuance of common stock for at-the-market offering, net Issuance of stock for public offerings, net Issuance of common stock related to equity plans
2023-12-31
2024-01-03 1507.34 未披露 定期报告 2023-12-28
2023-11-13 1482.78 342.71
更多>>
Common Stock offered 5,885,000 shares by the company
2023-11-14
2023-11-09 894.28 342.71 定期报告 2023-11-03
2023-10-09 890.00 未披露
更多>>
Fortress Biotech, Inc. announced that it will effect a 1-for-15 reverse stock split of its issued and outstanding common stock.
2023-10-10
2023-08-25 13308.73 未披露 定期报告 2023-08-15
2023-08-14 13278.73 342.71 定期报告 2023-08-09
2023-08-14 13165.74 342.71
更多>>
From March 31, 2023 to June 30, 2023 Common shares issued for dividend on partner company's convertible preferred shares Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net
2023-06-30
2023-05-15 13432.55 342.71 定期报告 2023-05-12
2023-04-28 13028.68 未披露 定期报告 2023-04-25
2023-05-15 13041.72 342.71
更多>>
From December 31, 2022 to March 31, 2023 Issuance of common stock for public offering, net Issuance of common stock for at-the-market offering, net Issuance of common stock related to equity plans
2023-03-31
2023-03-31 12976.31 未披露 定期报告 2023-03-27
2023-02-09 12713.71 未披露
更多>>
Common Stock offered 16,642,894 shares by the company
2023-02-10
2023-03-13 11344.20 未披露 定期报告 2023-02-09
2023-03-31 11049.42 342.71
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common stock for at-the-market offering, net Issuance of common stock related to equity plans
2022-12-31
2022-11-14 10861.52 342.71 定期报告 2022-11-07
2022-11-14 10825.94 342.71
更多>>
From June 30, 2022 to September 30, 2022 Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net
2022-09-30
2022-08-11 10773.48 342.71 定期报告 2022-08-08
2022-08-11 10771.76 342.71
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock related to equity plans Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net
2022-06-30
2022-05-12 10741.31 342.71 定期报告 2022-05-09
2022-05-02 10710.18 未披露 定期报告 2022-04-25
2022-05-12 10632.19 342.71
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net
2022-03-31
2022-03-28 10449.86 342.71 定期报告 2022-03-18
2022-03-28 10143.55 342.71
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock related to equity plans Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for dividend on partner company's convertible preferred shares
2021-12-31
2021-11-15 9962.94 342.71 定期报告 2021-11-11
2021-11-15 9871.42 342.71
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net Common shares issued for dividend on partner company's convertible preferred shares
2021-09-30
2021-08-16 10106.19 342.71 定期报告 2021-08-12
2021-08-16 9749.52 342.71
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common stock related to equity plans Issuance of common stock under ESPP Common shares issuable for dividend on partner company's convertible preferred shares
2021-06-30
2021-05-17 9731.92 342.71 定期报告 2021-05-13
2021-04-30 9725.39 未披露 定期报告 2021-04-20
2021-05-17 9726.31 342.71
更多>>
From December 31, 2020 To March 31, 2021 Issuance of common stock related to equity plans
2021-03-31
2021-03-31 9490.74 342.71 定期报告 2021-03-18
2021-03-31 9487.75 342.71
更多>>
From December 31, 2019 to December 31, 2020 Repurchase of Series A preferred stock, net Issuance of Series A preferred stock for cash, net Issuance of common stock related to equity plans Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Retirement of Series A preferred stock
2020-12-31
2020-11-09 9370.29 342.71 定期报告 2020-11-05
2020-11-09 9374.84 342.71
更多>>
From June 30, 2020 to September 30, 2020 Issuance of Series A preferred stock for cash, net Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense
2020-09-30
2020-08-10 8800.72 269.38 定期报告 2020-08-06
2020-08-10 8611.33 269.38
更多>>
From March 31, 2020 to June 30, 2020 Issuance of Series A preferred stock for cash, net Issuance of common stock related to equity plans Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Retirement of Series A preferred stock
2020-06-30
2020-05-11 8247.41 205.99 定期报告 2020-05-07
2020-04-27 8139.12 未披露 定期报告 2020-04-20
2020-05-11 7857.22 205.49
更多>>
From December 31, 2019 to March 31, 2020 Repurchase of Series A preferred stock, net Issuance of Series A preferred stock for cash, net Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net
2020-03-31
2020-03-16 7845.88 205.99 定期报告 2020-03-12
2020-03-16 7402.74 134.12
更多>>
from December 31, 2018 to December 31, 2019 Settlement of restricted stock units into common stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Issuance of Series A preferred stock for at-the-market offering, net Issuance of Series A preferred stock for cash, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense Common shares issued for Opus debt
2019-12-31
2019-11-12 7078.01 103.93 定期报告 2019-11-08
2019-11-12 7033.55 102.61
更多>>
from June 30, 2019 to September 30, 2019 Issuance of preferred A for at-the-market offering, net Issuance of restricted stock Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense Common shares issued for Opus debt
2019-09-30
2019-08-09 6904.24 未披露 定期报告 2019-08-06
2019-08-09 6813.82 100.00
更多>>
from December 31, 2018 to June 30, 2019 Issuance of restricted stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense
2019-06-30
2019-05-10 6523.06 未披露 定期报告 2019-05-08
2019-04-30 6422.76 未披露 定期报告 2019-04-24
2019-05-10 6312.65 100.00
更多>>
from December 31, 2018 to March 31, 2019 Issuance of restricted stock Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense
2019-03-31
2019-03-18 6130.23 未披露 定期报告 2019-03-14
2019-03-18 5784.54 100.00
更多>>
from December 31, 2017 to December 31, 2018 Settlement of restricted stock units into common stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense
2018-12-31
2018-11-09 5667.95 未披露 定期报告 2018-11-07
2018-11-09 5618.35 100.00
更多>>
from December 31, 2017 to September 30, 2018 Issuance of restricted stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense
2018-09-30
2018-08-09 5434.26 未披露 定期报告 2018-08-09
2018-08-09 5398.71 100.00
更多>>
from December 31, 2017 to June 30, 2018 Issuance of restricted stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering Common shares issued for 2017 Subordinated Note Financing interest expense
2018-06-30
2018-05-10 5290.21 未披露 定期报告 2018-05-09
2018-04-30 5294.55 未披露 定期报告 2018-04-16
2018-05-10 5268.65 100.00
更多>>
From December 31, 2017 to March 31, 2018 Issuance of restricted stock Issuance of common stock for at-the-market offering Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issuable for 2017 Subordinated Note Financing interest expense
2018-03-31
2018-03-16 5134.25 未披露 定期报告 2018-03-13
2018-03-16 5099.13 100.00
更多>>
from December 31, 2016 to December 31, 2017 Issuance of Series A preferred stock for cash, net of offering cost of $2,804 Exercise of options for cash Issuance of restricted stock Issuance of common stock under ESPP Issuance of common stock for research and development expenses Common shares issued for PIK interest expense
2017-12-31
2017-11-09 5065.65 未披露 定期报告 2017-11-09
2017-11-09 5058.49 未披露
更多>>
from December 31, 2016 to September 30, 2017 Exercise of options for cash Issuance of restricted stock Issuance of common stock under ESPP Common shares issued to NSC interest expense
2017-09-30
2017-08-09 5052.76 未披露 定期报告 2017-08-09
2017-08-09 5046.32 未披露
更多>>
from December 31, 2016 to June 30, 2017 Issuance of restricted stock Issuance of common stock under ESPP
2017-06-30
2017-05-10 5033.20 未披露 定期报告 2017-05-10
2017-04-26 5031.58 未披露 定期报告 2017-04-18
2017-05-10 5031.99 未披露
更多>>
from December 31, 2016 to March 31, 2017 Issuance of restricted stock
2017-03-31
2017-03-16 5031.99 未披露 定期报告 2017-03-15
2017-03-16 4893.20 未披露
更多>>
from December 31, 2015 to December 31, 2016 Issuance of restricted stock Cashless exercise of warrants Issuance of common stock for at-the-market offering Issuance of common stock under ESPP Cancellation of restricted stock
2016-12-31
2016-11-09 4887.51 未披露
更多>>
From December 31, 2015 to September 30, 2016 Issuance of restricted stock Cashless exercise of warrants Issuance of common stock for At-the-Market offering Issuance of common stock under ESPP Cancellation of restricted stock
2016-09-30
2016-08-18 4870.00 未披露 定期报告 2016-08-17
2016-08-09 4866.86 未披露 定期报告 2016-06-30
2016-05-10 4851.74 未披露 定期报告 2016-03-31
2016-03-15 4851.74 未披露 定期报告 2016-03-15
2016-03-15 4714.70 未披露
更多>>
From December 31, 2014 to December 31, 2015 Exercise of options Issuance of restricted stock Issuance of common stock under ESPP
2015-12-31
2015-11-09 4713.37 未披露 定期报告 2015-09-30
2015-08-10 4683.37 未披露 定期报告 2015-06-30
2015-06-04 4683.37 未披露 定期报告 2015-06-01
2015-05-11 4681.90 未披露 定期报告 2015-03-31
2015-03-16 4649.85 未披露 定期报告 2015-03-13
2015-03-16 4649.40 未披露
更多>>
from December 31, 2013 to December 31, 2014 Exercise of stock options Issuance of Common Stock related to subscription Issuance of Common Stock under ESPP Issuance of Restricted Stock
2014-12-31
2014-08-11 4431.22 未披露 定期报告 2014-06-30
2014-04-30 4430.51 未披露 定期报告 2014-04-22
2014-05-12 4425.34 未披露 定期报告 2014-03-31
2014-03-14 4408.64 未披露 定期报告 2014-03-12
2014-03-14 3965.30 未披露
更多>>
from December 31, 2012 to December 31, 2013 Exercise of stock options Exercise of warrants Issuance of Common stock under ESPP Issuance of Common stock for At the Market Offering Issuance of Restricted Stock
2013-12-31
2013-11-01 3561.19 未披露 定期报告 2013-10-30
2013-11-01 3525.57 未披露
更多>>
from December 31, 2012 to September 30, 2013 Exercise of Common Stock options Exercise of Common Stock warrants Sale of Common Stock under ATM programs Issuance of Common Stock related to the ESPP
2013-09-30
2013-08-30 3394.42 未披露 定期报告 2013-08-28
2013-08-16 3309.69 未披露 定期报告 2013-08-13
2013-08-05 3190.13 未披露 定期报告 2013-08-02
2013-07-12 3081.90 未披露 定期报告 2013-07-11
2013-08-05 2960.55 未披露 定期报告 2013-06-30
2013-05-09 2804.83 未披露 定期报告 2013-05-06
2013-05-15 2799.51 未披露 定期报告 2013-05-01
2013-05-09 2616.78 未披露 定期报告 2013-03-31
2013-03-18 2602.35 未披露 定期报告 2013-03-11
2013-03-18 2440.08 未披露
更多>>
from December 31, 2011 to December 31, 2012 Issuance of Common stock for cash Exercise of warrants Issuance of Common stock under ESPP Issuance of Common stock for At the Market Offering
2012-12-31
2012-11-14 2437.91 未披露 定期报告 2012-11-13
2012-08-08 2437.57 未披露 定期报告 2012-06-30
2012-05-15 1862.57 未披露 定期报告 2012-05-15
2012-03-29 1860.42 未披露
更多>>
from Dec 31,2010 to Dec 31,2011 Issuance of Convertible Preferred Stock Series B for purchase of Asphelia assets Issuance of Convertible Preferred Stock Series C for cash Issuance of Common Stock for conversion of Convertible Preferred Stock Series A Issuance of Common Stock for conversion of Convertible Preferred Stock Series B Issuance of Common Stock for conversion of Convertible Preferred Stock Series C Issuance of Common Stock dividend to Preferred Stock Series A stockholders Exercise of stock options In November 2011, all of our then outstanding shares of preferred stock were converted, on a one-for-one basis, into 11,496,186 shares of our common stock.
2011-12-31
From December 31, 2022 to December 31, 2023 Exercise of warrants for cash Common shares issued for dividend on partner company's convertible preferred shares Issuance of common stock for at-the-market offering, net Issuance of stock for public offerings, net Issuance of common stock related to equity plans
Common Stock offered 5,885,000 shares by the company
Fortress Biotech, Inc. announced that it will effect a 1-for-15 reverse stock split of its issued and outstanding common stock.
From March 31, 2023 to June 30, 2023 Common shares issued for dividend on partner company's convertible preferred shares Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net
From December 31, 2022 to March 31, 2023 Issuance of common stock for public offering, net Issuance of common stock for at-the-market offering, net Issuance of common stock related to equity plans
Common Stock offered 16,642,894 shares by the company
From December 31, 2021 to December 31, 2022 Issuance of common stock for at-the-market offering, net Issuance of common stock related to equity plans
From June 30, 2022 to September 30, 2022 Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net
From March 31, 2022 to June 30, 2022 Issuance of common stock related to equity plans Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net
From December 31, 2021 to March 31, 2022 Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net
From December 31, 2020 to December 31, 2021 Issuance of common stock related to equity plans Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for dividend on partner company's convertible preferred shares
From June 30, 2021 to September 30, 2021 Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net Common shares issued for dividend on partner company's convertible preferred shares
From March 31, 2021 to June 30, 2021 Issuance of common stock related to equity plans Issuance of common stock under ESPP Common shares issuable for dividend on partner company's convertible preferred shares
From December 31, 2020 To March 31, 2021 Issuance of common stock related to equity plans
From December 31, 2019 to December 31, 2020 Repurchase of Series A preferred stock, net Issuance of Series A preferred stock for cash, net Issuance of common stock related to equity plans Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Retirement of Series A preferred stock
From June 30, 2020 to September 30, 2020 Issuance of Series A preferred stock for cash, net Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense
From March 31, 2020 to June 30, 2020 Issuance of Series A preferred stock for cash, net Issuance of common stock related to equity plans Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Retirement of Series A preferred stock
From December 31, 2019 to March 31, 2020 Repurchase of Series A preferred stock, net Issuance of Series A preferred stock for cash, net Issuance of common stock related to equity plans Issuance of common stock for at-the-market offering, net
from December 31, 2018 to December 31, 2019 Settlement of restricted stock units into common stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Issuance of Series A preferred stock for at-the-market offering, net Issuance of Series A preferred stock for cash, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense Common shares issued for Opus debt
from June 30, 2019 to September 30, 2019 Issuance of preferred A for at-the-market offering, net Issuance of restricted stock Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense Common shares issued for Opus debt
from December 31, 2018 to June 30, 2019 Issuance of restricted stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense
from December 31, 2018 to March 31, 2019 Issuance of restricted stock Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense
from December 31, 2017 to December 31, 2018 Settlement of restricted stock units into common stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering, net Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense
from December 31, 2017 to September 30, 2018 Issuance of restricted stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issued for Opus interest expense
from December 31, 2017 to June 30, 2018 Issuance of restricted stock Issuance of common stock under ESPP Issuance of common stock for at-the-market offering Common shares issued for 2017 Subordinated Note Financing interest expense
From December 31, 2017 to March 31, 2018 Issuance of restricted stock Issuance of common stock for at-the-market offering Common shares issued for 2017 Subordinated Note Financing interest expense Common shares issuable for 2017 Subordinated Note Financing interest expense
from December 31, 2016 to December 31, 2017 Issuance of Series A preferred stock for cash, net of offering cost of $2,804 Exercise of options for cash Issuance of restricted stock Issuance of common stock under ESPP Issuance of common stock for research and development expenses Common shares issued for PIK interest expense
from December 31, 2016 to September 30, 2017 Exercise of options for cash Issuance of restricted stock Issuance of common stock under ESPP Common shares issued to NSC interest expense
from December 31, 2016 to June 30, 2017 Issuance of restricted stock Issuance of common stock under ESPP
from December 31, 2016 to March 31, 2017 Issuance of restricted stock
from December 31, 2015 to December 31, 2016 Issuance of restricted stock Cashless exercise of warrants Issuance of common stock for at-the-market offering Issuance of common stock under ESPP Cancellation of restricted stock
From December 31, 2015 to September 30, 2016 Issuance of restricted stock Cashless exercise of warrants Issuance of common stock for At-the-Market offering Issuance of common stock under ESPP Cancellation of restricted stock
From December 31, 2014 to December 31, 2015 Exercise of options Issuance of restricted stock Issuance of common stock under ESPP
from December 31, 2013 to December 31, 2014 Exercise of stock options Issuance of Common Stock related to subscription Issuance of Common Stock under ESPP Issuance of Restricted Stock
from December 31, 2012 to December 31, 2013 Exercise of stock options Exercise of warrants Issuance of Common stock under ESPP Issuance of Common stock for At the Market Offering Issuance of Restricted Stock
from December 31, 2012 to September 30, 2013 Exercise of Common Stock options Exercise of Common Stock warrants Sale of Common Stock under ATM programs Issuance of Common Stock related to the ESPP
from December 31, 2011 to December 31, 2012 Issuance of Common stock for cash Exercise of warrants Issuance of Common stock under ESPP Issuance of Common stock for At the Market Offering
from Dec 31,2010 to Dec 31,2011 Issuance of Convertible Preferred Stock Series B for purchase of Asphelia assets Issuance of Convertible Preferred Stock Series C for cash Issuance of Common Stock for conversion of Convertible Preferred Stock Series A Issuance of Common Stock for conversion of Convertible Preferred Stock Series B Issuance of Common Stock for conversion of Convertible Preferred Stock Series C Issuance of Common Stock dividend to Preferred Stock Series A stockholders Exercise of stock options In November 2011, all of our then outstanding shares of preferred stock were converted, on a one-for-one basis, into 11,496,186 shares of our common stock.